09/03/2019 / By Evangelyn Rodriguez
In this study, researchers from Fudan University in China developed a pharmacokinetic model for sodium tanshinone IIA sulfonate (STS) based on healthy volunteers and patients with coronary heart disease (CHD). The details of this developmental study were published in the Chinese Journal of Natural Medicines.
Based on these results, the researchers concluded that STS dosage adjustment should be considered based on the TBIL levels of CHD patients.
Journal Reference:
Qin WW, Wang L, Jiao Z, Wang B, Wang CY, Qian LX, Qi WL, Zhong MK. LOWER CLEARANCE OF SODIUM TANSHINONE IIA SULFONATE IN CORONARY HEART DISEASE PATIENTS AND THE EFFECT OF TOTAL BILIRUBIN: A POPULATION PHARMACOKINETICS ANALYSIS. Chinese Journal of Natural Medicines. March 2019;17(3):218–226. DOI: 10.1016/s1875-5364(19)30024-x
Tagged Under: alternative medicine, bilirubin, Chinese medicine, coronary heart disease, disease treatments, heart health, herbal medicine, Herbs, natural cures, natural medicine, phamacokinetics, plant cures, plant medicine, red sage, research, sodium tanshinone IIA sulfonate, TCM
PlantMedicine.News is a fact-based public education website published by Plant Medicine News Features, LLC.
All content copyright © 2018 by Plant Medicine News Features, LLC.
Contact Us with Tips or Corrections
All trademarks, registered trademarks and servicemarks mentioned on this site are the property of their respective owners.